Healthcare Services

BNP And NTproBNP Market Revenue Expected to Reach $4.02 Billion by 2030 with 12.3% CAGR

March 30, 2026March 30, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Expected Market Size Of The BNP And NTproBNP Market From 2026 To 2030?

The bnp and ntprobnp market has shown rapid expansion in recent years. Its size is expected to increase from $2.26 billion in 2025 to $2.54 billion in 2026, achieving a compound annual growth rate (CAGR) of 12.2%. This historical growth can be attributed to the rising prevalence of cardiovascular diseases, increased clinical adoption of bnp testing, expansion of hospital diagnostic infrastructure, growing awareness regarding early heart failure detection, and the availability of laboratory immunoassay technologies.

The bnp and ntprobnp market size is projected to experience substantial expansion over the upcoming years. It is anticipated to reach a valuation of $4.03 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.3%. This anticipated increase throughout the forecast period stems from factors such as a heightened demand for swift cardiac diagnostics, wider embrace of point-of-care testing, an expanding senior demographic, increasing incorporation of AI-assisted diagnostic analysis, and a greater emphasis on preventive cardiology. Key developments during this timeframe are expected to involve the rising implementation of high-sensitivity cardiac biomarker assays, greater utilization of point-of-care bnp testing devices, enhanced integration of automated laboratory diagnostics, broader rollout of early heart failure screening initiatives, and an intensified focus on diagnostics with quick results.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10673&type=smp

What Drivers Are Influencing The BNP And NTproBNP Market?

The increasing number of older adults is anticipated to boost the expansion of the BNP and NT-proBNP market in the coming years. This demographic encompasses older individuals, generally classified as those aged 65 and above. For this elderly demographic, BNP and NT-proBNP function as essential indicators, facilitating the detection and treatment of heart failure through offering key information on heart performance and assisting in determining suitable therapeutic approaches. As an illustration, in October 2025, data from the World Health Organization, a US-based specialized health agency, indicates that globally, 1 in 6 individuals will be 60 or older by 2030 and is expected to reach 2.1 billion elderly people by 2050. Consequently, the expansion of the geriatric population is fueling the development of the BNP and NT-proBNP market.

Which Segments Are Included In The Analysis Of The BNP And NTproBNP Market?

The bnp and ntprobnp market covered in this report is segmented –

1) By Type: BNP (Brain Natriuretic Peptide), NT-proBNP (N-terminal Pro–B-Type Natriuretic Peptide)

2) By Location Of Testing: Point Of Care Testing, Laboratory Testing

3) By Application: Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome (ACS), Other Applications

Subsegments:

1) By BNP (Brain Natriuretic Peptide): BNP Testing Kits, Point-Of-Care BNP Testing Devices, Laboratory BNP Assays

2) By NT-ProBNP (N-Terminal Pro–B-Type Natriuretic Peptide): NT-ProBNP Testing Kits, Point-Of-Care NT-proBNP Testing Devices, Laboratory NT-ProBNP Assays

What Trends Are Advancing Progress In The BNP And NTproBNP Market?

Major companies operating in the BNP and NTproBNP market are increasingly focusing on introducing rapid screening bioassays to gain a competitive edge. Rapid screening bioassays are biological tests that effectively evaluate the presence, concentration, or activity of a substance by assessing its effects on living cells or organisms, enabling quick and dependable identification or classification of specific attributes or conditions. For instance, in October 2023, Mindray Medical International Limited, a China-based medical device company, released two new assays designed to aid in the diagnosis and management of cardiovascular diseases (CVDs). These assays are named high-sensitivity troponin I (hs-cTnI) and N-terminal pro-B-type natriuretic peptide (NT-proBNP). By adding these new assays to its diverse portfolio of cardiac biomarkers, Mindray has improved its capability to screen, stratify risk, rapidly diagnose, and monitor therapy for CVDs. Mindray collaborated with HyTest, a pioneer in cardiac biomarkers, to incorporate HyTest’s research and antibodies into Mindray’s immunoassay platforms.

Which Key Industry Participants Are Active In The BNP And NTproBNP Market?

Major companies operating in the bnp and ntprobnp market are Abbott Laboratories, Gentian Diagnostics ASA, Siemens AG, PerkinElmer Inc., Biomerieux SA, Quidel Corporation, Bio-Rad Laboratories Inc., F Hoffman La Roche Ltd., CTK Biotech Inc., RayBiotech Life Inc., BHR Pharmaceuticals Ltd., Getein Biotech Inc., VACURE Biotechnology Co. Ltd., Bio-Techne Co., Xiamen Biotime Biotechnology Co. Ltd., Scripps Laboratories Inc., Danaher Corporation, Beckman Coulter Inc., Thermo Fisher Scientific Inc., Randox Laboratories Ltd., LSI Medience Corporation, Shionogi & Co. Ltd., Radiometer Medical ApS, Ortho Clinical Diagnostics, Tosoh Corporation, Aidian Oy, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Becton Dickinson and Company, Acon Laboratories Inc., Response Biomedical Corp., Nanomix Inc., Cepheid Inc., Alere Inc.

Read the full bnp and ntprobnp market report here:

https://www.thebusinessresearchcompany.com/report/bnp-and-ntprobnp-global-market-report

Which Regions Are Expected To Experience Rapid Expansion In The BNP And NTproBNP Market?

Asia-Pacific was the largest region in the BNP and NTproBNP market in 2025.North America is expected to be the fastest-growing region in the global BNP and NTproBNP market report during the forecast period. The regions covered in the bnp and ntprobnp market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored BNP And NTproBNP Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=10673&type=smp

Browse Through More Reports Similar to the Global BNP And NTproBNP Market 2026, By The Business Research Company

B2B2C Insurance Global Market Report

https://www.thebusinessresearchcompany.com/report/b2b2c-insurance-global-market-report

B2B Telecommunication Global Market Report

https://www.thebusinessresearchcompany.com/report/b2b-telecommunication-global-market-report

Consumer And Smb Nas Global Market Report

https://www.thebusinessresearchcompany.com/report/consumer-and-smb-nas-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795